Massive chinese trial tests simple steps to prevent deadly clots in hospitals

NCT ID NCT04211181

Recruiting now Knowledge-focused Sponsor: China-Japan Friendship Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a set of quality improvement tools—including guidelines, care protocols, and a mobile app—can help hospitals in China better prevent blood clots in patients. About 5,800 hospitalized adults will take part across multiple hospitals. The goal is to see if the program increases the number of at-risk patients who receive proper prevention and reduces clot-related complications within 90 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: quality improvement program (guidelines, protocols, mobile app)
What this could lead to: If successful, this could provide a practical way for hospitals to better prevent dangerous blood clots in patients, reducing deaths and complications.
What could go wrong: This is a large but early-stage implementation study, not testing a new drug. Results may vary by hospital and may not apply outside China.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEEP VENOUS THROMBOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pulmonary embolism venous thromboembolism Venous Thrombosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEEP VENOUS THROMBOSIS PULMONARY EMBOLISM QUALITY IMPROVEMENT VENOUS THROMBOEMBOLIC DISEASE VENOUS THROMBOEMBOLISM

Contacts and locations

Locations

China-Japan Friendship Hospital
RECRUITING

Beijing, Beijing Municipality, 100029, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.